title: Progression of undiagnosed cutaneous T-cell lymphoma during efalizumab therapy.
authors.forename: Claudia
authors.initials: C
authors.lastname: Hernandez
authors.forename: Sophie M
authors.initials: SM
authors.lastname: Worobec
authors.forename: Sujata S
authors.initials: SS
authors.lastname: Gaitonde
authors.forename: Monika L
authors.initials: ML
authors.lastname: Kiripolsky
authors.forename: Kristen
authors.initials: K
authors.lastname: Aquino
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018450:Disease Progression; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000175:diagnosis / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab